{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:10:09Z","timestamp":1790075409647,"version":"4.0.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDT"],"published-print":{"date-parts":[[2026,9,18]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Eye disorders such as age-related macular degeneration, diabetic retinopathy,\nglaucoma, and uveitis persist as prominent contributors to visual impairment on a global scale.\nConventional ocular drug delivery systems face a range of physiological hurdles, including tear film\nclearance, epithelium absorption, conjunctival absorption, and the formidable blood-retinal barrier.\nThese challenges culminate in suboptimal ocular bioavailability, frequently compelling healthcare\nproviders to resort to invasive drug administration methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This review systematically evaluates recent literature focusing on exosome-based ocular\ndrug delivery systems. Published preclinical and clinical studies were identified through structured\nsearches of PubMed, Scopus, and Web of Science using the keywords \u201cexosomes\u201d, \u201cextracellular\nvesicles\u201d, \u201cocular drug delivery\u201d, \u201cretina\u201d, and \u201cophthalmology\u201d. The search covered studies published\nbetween 2000 and 2025 to understand exosome biology, isolation and characterization techniques,\ndrug-loading strategies, and their ability to overcome ocular physiological barriers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Exosomes are naturally occurring extracellular vesicles enriched with proteins, lipids, and\nnucleic acids, exhibiting excellent biocompatibility and intrinsic targeting capabilities. Evidence\nfrom preclinical studies demonstrates their ability to traverse ocular barriers and enhance drug retention\nand bioavailability. Emerging clinical investigations highlight their therapeutic promise in retinal\nand anterior segment disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Compared with synthetic nanocarriers, exosomes offer superior biological stability,\nreduced immunogenicity, and enhanced tissue penetration. However, challenges related to largescale\nproduction, standardization, storage stability, immunological safety, and regulatory approval\nremain critical barriers to clinical translation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Exosome-based ocular drug delivery represents a promising precision medicine strategy\nthat addresses long-standing limitations of conventional ophthalmic therapies. Continued advances in\nformulation optimization, scalable manufacturing, and regulatory frameworks are expected to accelerate\ntheir clinical and commercial translation for patient-centered eye care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113894501468995260904090347","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:57:57Z","timestamp":1790074677000},"source":"Crossref","is-referenced-by-count":0,"title":["Exosomes in Ophthalmology: Bridging Physiological Barriers for Precision Ocular Drug Delivery"],"prefix":"10.2174","volume":"27","author":[{"given":"Haranath","family":"Chinthaginjala","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research (Autonomous), KR. Palli Cross, 515721, Ananthapuramu, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhargav","family":"E.","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research (Autonomous), KR. Palli Cross, 515721, Ananthapuramu, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Thriveni","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research (Autonomous), KR. Palli Cross, 515721, Ananthapuramu, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Vamsi","family":"Vardhan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research (Autonomous), KR. Palli Cross, 515721, Ananthapuramu, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sai Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research (Autonomous), KR. Palli Cross, 515721, Ananthapuramu, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0390-0982","authenticated-orcid":true,"given":"Maddileti","family":"Repollu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research (Autonomous), KR. Palli Cross, 515721, Ananthapuramu, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501468995260904090347","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/258514\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501468995260904090347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:58:01Z","timestamp":1790074681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/258514\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113894501468995260904090347","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}